Literature DB >> 19864612

Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides.

Ana M Avalos1, Eicke Latz, Betty Mousseau, Sean R Christensen, Mark J Shlomchik, Frances Lund, Ann Marshak-Rothstein.   

Abstract

Synthetic oligonucleotides containing CpG motifs have been shown to induce proliferation, differentiation, and cytokine production in B cells, macrophages, and dendritic cells through a TLR9-dependent mechanism. A class (CpG-A) and B class (CpG-B) oligonucleotides display distinct physical properties. CpG-A, but not CpG-B, can multimerize to form exceedingly large lattices. CpG-A cannot effectively activate B cells but does induce plasmacytoid dendritic cells to produce high levels of IFNalpha, while CpG-B is a potent B cell mitogen. In this study, we report that CpG-A is internalized by B cells, and CpG-A and CpG-B accumulate in distinct intracellular compartments. When present in the form of an immune complex (CpG-A IC), CpG-A is taken up more efficiently by AM14 IgG2a-specific B cells, and elicits a robust TLR9-dependent B cell proliferative response. B cells proliferating comparably and in a TLR9-dependent fashion in response to CpG-A IC and CpG-B exhibited distinct cytokine profiles. CpG-A IC induced enhanced production of RANTES and markedly reduced levels of IL-6 when compared with CpG-B. We also found that engagement of the AM14 BCR by a protein IC, which cannot by itself induce proliferation, promoted TLR9-dependent but BCR-independent proliferation by bystander CpG-A or fragments of mammalian dsDNA. These data identify direct and indirect mechanisms by which BCR engagement facilitates access of exogenous ligands to TLR9-associated compartments and subsequent B cell activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864612      PMCID: PMC3426913          DOI: 10.4049/jimmunol.0901941

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Role of RANTES in the development of autoimmune tissue injuries in MRL-Fas lpr mice.

Authors:  Tsunemichi Tsukahara; Yasuhiko Makino; Takayuki Fujii; Makoto Ogawa; Hiromitsu Saisho; Yuki Hamano; Shiro Ueda; Bunshiro Akikusa; Theodore M Danoff
Journal:  Clin Immunol       Date:  2002-04       Impact factor: 3.969

2.  Entry of B cell antigen receptor and antigen into class II peptide-loading compartment is independent of receptor cross-linking.

Authors:  W Song; H Cho; P Cheng; S K Pierce
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

3.  Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs.

Authors:  D Verthelyi; K J Ishii; M Gursel; F Takeshita; D M Klinman
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

4.  Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide.

Authors:  Mayda Gürsel; Daniela Verthelyi; Ihsan Gürsel; Ken J Ishii; Dennis M Klinman
Journal:  J Leukoc Biol       Date:  2002-05       Impact factor: 4.962

5.  Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs.

Authors:  Z K Ballas; A M Krieg; T Warren; W Rasmussen; H L Davis; M Waldschmidt; G J Weiner
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

6.  Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.

Authors:  Elizabeth A Leadbetter; Ian R Rifkin; Andreas M Hohlbaum; Britte C Beaudette; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

7.  Activation of autoreactive B cells by CpG dsDNA.

Authors:  Gregory A Viglianti; Christina M Lau; Timothy M Hanley; Benjamin A Miko; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

8.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome.

Authors:  Eicke Latz; Annett Schoenemeyer; Alberto Visintin; Katherine A Fitzgerald; Brian G Monks; Cathrine F Knetter; Egil Lien; Nadra J Nilsen; Terje Espevik; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2004-01-11       Impact factor: 25.606

9.  Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha.

Authors:  Melissa B Uccellini; Liliana Busconi; Nathaniel M Green; Patricia Busto; Sean R Christensen; Mark J Shlomchik; Ann Marshak-Rothstein; Gregory A Viglianti
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

10.  Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices.

Authors:  A M Pearson; A Rich; M Krieger
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

View more
  21 in total

Review 1.  Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

Review 2.  Accessory molecules for Toll-like receptors and their function.

Authors:  Clarissa C Lee; Ana M Avalos; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2012-02-03       Impact factor: 53.106

3.  Selective binding of anti-DNA antibodies to native dsDNA fragments of differing sequence.

Authors:  Melissa B Uccellini; Patricia Busto; Michelle Debatis; Ann Marshak-Rothstein; Gregory A Viglianti
Journal:  Immunol Lett       Date:  2012-01-21       Impact factor: 3.685

4.  Absence of surrogate light chain results in spontaneous autoreactive germinal centres expanding V(H)81X-expressing B cells.

Authors:  Ola Grimsholm; Weicheng Ren; Angelina I Bernardi; Haixia Chen; Giljun Park; Alessandro Camponeschi; Dongfeng Chen; Berglind Bergmann; Nina Höök; Sofia Andersson; Anneli Strömberg; Inger Gjertsson; Susanna Cardell; Ulf Yrlid; Alessandra De Riva; Inga-Lill Mårtensson
Journal:  Nat Commun       Date:  2015-05-11       Impact factor: 14.919

5.  HSV-1/TLR9-Mediated IFNβ and TNFα Induction Is Mal-Dependent in Macrophages.

Authors:  Joanna Zyzak; Małgorzata Mitkiewicz; Ewa Leszczyńska; Patryk Reniewicz; Paul N Moynagh; Jakub Siednienko
Journal:  J Innate Immun       Date:  2019-12-18       Impact factor: 7.349

Review 6.  Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity.

Authors:  Damir Matesic; Aleksander Lenert; Petar Lenert
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.806

7.  B Cells Produce Type 1 IFNs in Response to the TLR9 Agonist CpG-A Conjugated to Cationic Lipids.

Authors:  Munir Akkaya; Billur Akkaya; Pietro Miozzo; Mukul Rawat; Mirna Pena; Patrick W Sheehan; Ann S Kim; Olena Kamenyeva; Juraj Kabat; Silvia Bolland; Akanksha Chaturvedi; Susan K Pierce
Journal:  J Immunol       Date:  2017-06-26       Impact factor: 5.422

8.  CpG and non-CpG oligodeoxynucleotides directly costimulate mouse and human CD4+ T cells through a TLR9- and MyD88-independent mechanism.

Authors:  Angela Landrigan; Michael T Wong; Paul J Utz
Journal:  J Immunol       Date:  2011-08-15       Impact factor: 5.422

9.  Cell-specific TLR9 trafficking in primary APCs of transgenic TLR9-GFP mice.

Authors:  Ana M Avalos; Oktay Kirak; J Margit Oelkers; Marina C Pils; You-Me Kim; Matthias Ottinger; Rudolf Jaenisch; Hidde L Ploegh; Melanie M Brinkmann
Journal:  J Immunol       Date:  2012-12-12       Impact factor: 5.422

Review 10.  Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.

Authors:  Petar S Lenert
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.